Rankiteo Logo
Rankiteo
Leader in Cyber Underwriting
Loading...
NEWRankiteo Cyber Underwriting Desktop - Score, price, and bind from your desktop
WindowsmacOSLinux
Download

Comparison Overview

Wanbang Biopharmaceuticals Co. LtdWanbang Biopharmaceuticals Co. Ltd
VS
Zydus GroupZydus Group
Wanbang Biopharmaceuticals Co. Ltd

Wanbang Biopharmaceuticals Co. Ltd

经济开发区杨山路, 徐州市, 江苏省, 221004, CN

Last Update: 10/12/2025

View Profile
Between 750 and 799
http://www.chinawanbang.com/
751/1000Fair

The Brief Introduction of Wanbang Biopharmaceuticals Wanbang Biopharmaceuticals (brief in “Wanbang Biopharma”) is the core member of Shanghai Fosun Pharmaceutical (Group) Co., Ltd (brief in “Fosun Pharma”, stock code: 600196-SH, 02196-HK). Wanbang Biopharma was establis...

NAICS:3254
NAICS Definition:Pharmaceutical and Medicine Manufacturing
Employees:12
Subsidiaries:28
12-month incidents
0
Known data breaches
0
Attack type number
0
Zydus Group

Zydus Group

Zydus Corporate Park, Nr. Nirma University, Vasihnodevi circle, Mouje - Khoraj, Sarkhej - Gandhinagar Highway, Ahmedabad, Gujarat, IN, 382481

Last Update: 03/04/2026

View Profile
Between 750 and 799
http://www.zyduslife.com
780/1000Fair

The Zydus Group with an overarching purpose of empowering people with freedom to live healthier and more fulfilled lives, is an innovative, global life-sciences company that discovers, develops, manufactures, and markets a broad range of healthcare therapies. The group ...

NAICS:3254
NAICS Definition:Pharmaceutical and Medicine Manufacturing
Employees:20,544
Subsidiaries:0
12-month incidents
0
Known data breaches
0
Attack type number
0

Compliance Ranges Comparison

Based On Specific Ai Models Category
Wanbang Biopharmaceuticals Co. Ltd

Wanbang Biopharmaceuticals Co. Ltd

-
ISO 27001Not verified
ISO 27001
-
SOC2 Type 1Not verified
SOC2 Type 1
-
SOC2 Type 2Not verified
SOC2 Type 2
-
GDPRNot verified
GDPR
-
PCI DSSNot verified
PCI DSS
-
HIPAANot verified
HIPAA
Zydus Group

Zydus Group

-
ISO 27001Not verified
ISO 27001
-
SOC2 Type 1Not verified
SOC2 Type 1
-
SOC2 Type 2Not verified
SOC2 Type 2
-
GDPRNot verified
GDPR
-
PCI DSSNot verified
PCI DSS
-
HIPAANot verified
HIPAA

Benchmark & Cyber Underwriting Signals

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for Wanbang Biopharmaceuticals Co. Ltd in 2026.

Incidents

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for Zydus Group in 2026.

Incidents

Incident History - Wanbang Biopharmaceuticals Co. Ltd (X = Date, Y = Severity)

Wanbang Biopharmaceuticals Co. Ltd cyber incidents detection timeline including parent company and subsidiaries.

No timeline data available
R - Ransomware
C - Cyber Attack
D - Data Breach
V - Vulnerability

Incident History - Zydus Group (X = Date, Y = Severity)

Zydus Group cyber incidents detection timeline including parent company and subsidiaries.

No timeline data available
R - Ransomware
C - Cyber Attack
D - Data Breach
V - Vulnerability

Notable Incidents

Last Cyber / HR Incidents / Global...
Wanbang Biopharmaceuticals Co. Ltd

Wanbang Biopharmaceuticals Co. Ltd

Incidents
No explicit notable incidents reported.
Zydus Group

Zydus Group

Incidents
No explicit notable incidents reported.

FAQ

Between Wanbang Biopharmaceuticals Co. Ltd company and Zydus Group company, which one has the best AI Cybersecurity Score ?
Between Wanbang Biopharmaceuticals Co. Ltd company and Zydus Group company, which one has experienced more cyber incidents in the past ?
Between Wanbang Biopharmaceuticals Co. Ltd company and Zydus Group company, which one has experienced more cyber incidents this year ?
Between Wanbang Biopharmaceuticals Co. Ltd company and Zydus Group company, which one has experienced at least one ransomware attack ?
Between Wanbang Biopharmaceuticals Co. Ltd company and Zydus Group company, which one has experienced at least one data breach ?
Between Wanbang Biopharmaceuticals Co. Ltd company and Zydus Group company, which one has experienced at least one targeted cyberattack ?
Between Wanbang Biopharmaceuticals Co. Ltd company and Zydus Group company, which one has experienced at least one vulnerability ?
Between Wanbang Biopharmaceuticals Co. Ltd company and Zydus Group company, which one holds the most compliance certifications ?
Between Wanbang Biopharmaceuticals Co. Ltd company and Zydus Group company, which one holds the fewest compliance certifications ?
Between Wanbang Biopharmaceuticals Co. Ltd company and Zydus Group company, which one has the most subsidiaries ?
Between Wanbang Biopharmaceuticals Co. Ltd company and Zydus Group company, which one has the largest number of employees ?
Between Wanbang Biopharmaceuticals Co. Ltd and Zydus Group, which company holds both SOC 2 Type 1 certifications ?
Between Wanbang Biopharmaceuticals Co. Ltd and Zydus Group, which company holds both SOC 2 Type 2 certifications ?
Which company is ISO 27001 certified - Wanbang Biopharmaceuticals Co. Ltd or Zydus Group ?
Which company is PCI DSS compliant - Wanbang Biopharmaceuticals Co. Ltd or Zydus Group ?
Between Wanbang Biopharmaceuticals Co. Ltd and Zydus Group, which company complies with HIPAA regulations for healthcare data ?
Between Wanbang Biopharmaceuticals Co. Ltd and Zydus Group, which company complies with GDPR requirements ?

Latest Global CVEs

CVE-2026-10777
SUMMARY

A vulnerability was identified in ealpha072 Student-Management-System up to 01451bd7a2f58cdda07bd0b86e3967582e3ecd08. Affected by this issue is some unknown functionality of the file admin/config.php of the component Administrative Backend. Such manipulation leads to improper authentication. The attack may be performed from remote. The exploit is publicly available and might be used. This product utilizes a rolling release system for continuous delivery, and as such, version information for affected or updated releases is not disclosed. The project was informed of the problem early through an issue report but has not responded yet.

PUBLISHED
Date2026-06-03
UPDATED
Date2026-06-03
RISK INFORMATION (Score: 7.3)
CVSS2
Base Score: 7.5
Complexity: LOW
AV:N/AC:L/Au:N/C:P/I:P/A:P
CVSS3
Base Score: 7.3
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:L/A:L
CVSS4
Base Score: 5.5
Complexity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:L/VI:L/VA:L/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
3.4
EXPLOITABILITY
3.9
CVE-2026-10775
SUMMARY

A vulnerability was determined in sgl-project SGLang up to 0.5.11. Affected by this vulnerability is the function data_hash of the component Cache Handler. This manipulation causes denial of service. The attack is restricted to local execution. A high degree of complexity is needed for the attack. The exploitation appears to be difficult. The exploit has been publicly disclosed and may be utilized. The pull request to fix this issue awaits acceptance.

PUBLISHED
Date2026-06-03
UPDATED
Date2026-06-03
RISK INFORMATION (Score: 3.6)
CVSS2
Base Score: 2.4
Complexity: HIGH
AV:L/AC:H/Au:S/C:N/I:P/A:P
CVSS3
Base Score: 3.6
Complexity: HIGH
CVSS:3.1/AV:L/AC:H/PR:L/UI:N/S:U/C:N/I:L/A:L
CVSS4
Base Score: 1.1
Complexity: HIGH
CVSS:4.0/AV:L/AC:H/AT:N/PR:L/UI:N/VC:N/VI:L/VA:L/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
2.5
EXPLOITABILITY
1
CVE-2026-22055
SUMMARY

Active IQ OneCollect version 2.7.3 contains hard-coded credentials that could allow an authenticated attacker with low privileges to perform unauthorized AutoSupport operations.

PUBLISHED
Date2026-06-03
UPDATED
Date2026-06-03
RISK INFORMATION (Score: )
CVSS4
Base Score: 5.3
Complexity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:N/VI:N/VA:N/SC:L/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
NA
EXPLOITABILITY
NA
CVE-2026-22054
SUMMARY

Active IQ Config Advisor version 6.7.3 contains hard-coded credentials that could allow an authenticated attacker with low privileges to perform unauthorized AutoSupport operations.

PUBLISHED
Date2026-06-03
UPDATED
Date2026-06-03
RISK INFORMATION (Score: )
CVSS4
Base Score: 5.3
Complexity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:N/VI:N/VA:N/SC:L/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
NA
EXPLOITABILITY
NA
CVE-2026-10771
SUMMARY

A vulnerability was found in crmeb crmeb_java 1.4. Affected is the function RestTemplate.getForEntity of the file crmeb-common/src/main/java/com/zbkj/common/utils/RestTemplateUtil.java of the component base64 Qrcode Endpoint. The manipulation of the argument url results in server-side request forgery. The attack can be executed remotely. The exploit has been made public and could be used. The project was informed of the problem early through an issue report but has not responded yet.

PUBLISHED
Date2026-06-03
UPDATED
Date2026-06-03
RISK INFORMATION (Score: 7.3)
CVSS2
Base Score: 7.5
Complexity: LOW
AV:N/AC:L/Au:N/C:P/I:P/A:P
CVSS3
Base Score: 7.3
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:L/A:L
CVSS4
Base Score: 5.5
Complexity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:L/VI:L/VA:L/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
3.4
EXPLOITABILITY
3.9